Skip to main content
Log in

Aminoglutethimide

Penetration of the blood brain barrier

  • Preclinical Studies
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

Abstract

The uptake of 14C-labeled aminoglutethimide into the brain was investigated in the rat after intracarotid injection according to the method of Oldendorf, as well as in cisternal cerebrospinal fluid obtained by suboccipital puncture after i.v. injection of the drug. The brain uptake index of aminoglutethimide after intracarotid injection was 30.7 + 2.4%. Cerebrospinal fluid/blood quotients after i.v. drug injection were 0.53 at 10 min and 0.26 at 60 min. The results of both methods clearly show that aminoglutethimide easily penetrates the blood brain barrier.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Longcope L, Pratt JH, Schneider SH, Fineberg SE: Aromatization of androgens by muscle and adipose tissue in vivo. J Clin Endocrinol Metab 46:146–152, 1978

    Google Scholar 

  2. Abul-Haji YJ, Iverson R, Kiang DT: Aromatization of androgens by human breast cancer. Steroids 33:205–222, 1979

    Google Scholar 

  3. Miller WR, Forrest APM: Estradiol synthesis by a human breast cancer. Lancet 2:866–868, 1974

    Google Scholar 

  4. Nicholls PJ, Dalrymle PD, Eweiss N, Douglas JS: Aminoglutethimide: absorption, physiological disposition and pharmacokinetics. In: Nagel GA, Santen RJ (eds): Aminoglutethimide as an aromatase inhibitor in the treatment of cancer. Hans Huber Publishers, Berne-Stuttgart-Vienna, 1984, pp 58–67

    Google Scholar 

  5. Rabe T, Bauer M, Kaufmann M, Runnenbaum B, Kubli F: Inhibition of aromatase activity in human breast carcinoma by aminoglutethimide in vitro (Abstract). Acta Endocrinol 102:146, 1983

    Google Scholar 

  6. Varela RM, Dao TL: Estrogen synthesis and estradiol binding by human mammary tumors. Cancer Res 38:2429–2433, 1978

    Google Scholar 

  7. Oldendorf HW: Measurement of brain uptake of radio-labeled substances using a tritiated water internal standard. Brain Res 24:372–376, 1970

    Google Scholar 

  8. Unger C, Eibl H, von Heyden HW, Nagel GA: Ein neues Prinzip zur Überwindung der Blut-Hirn-Schranke. In: von Heyden HW, Krauseneck P (eds): Hirnmetastasen, Pathophysiologie, Diagnostik und Therapie. Zuckschwerdt Verlag, München, 1984, pp 31–38

    Google Scholar 

  9. Reiber H, Schunck O: Suboccipital puncture of guinea pigs. Laboratory Animals 17:25–27, 1983

    Google Scholar 

  10. Oldendorf HW: Lipid solubility and drug penetration of the blood-brain barrier. Proc Soc Exp Biol Med 147:813–816, 1974

    Google Scholar 

  11. Perel E, Wilkins D, Killinger DW: The conversion of androstendione to estrone, estradiol, and testosterone in breast cancer tissue. J Steroid Biochem 13:89–94, 1980

    Google Scholar 

  12. Unger C, Eibl H, von Heyden HW, Nagel GA: Reversible opening of the blood-brain barrier for drug transfer by short chain alkyl glycerols. (Abstract) Proc Am Soc Clin Oncol 3:25, 1984

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Unger, C., Eibl, H., von Heyden, HW. et al. Aminoglutethimide. Invest New Drugs 4, 237–240 (1986). https://doi.org/10.1007/BF00179589

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00179589

Key words

Navigation